Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats
© 2016 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd Fibroblast growth factor 21 (FGF21) acts as a metabolic regulator and exerts cardioprotective effects. However, the effects of long-term FGF21 administration on the heart under the FGF21-resistant condition in obese,...
Saved in:
Main Authors: | P. Tanajak, P. Sa-Nguanmoo, X. Wang, G. Liang, X. Li, C. Jiang, S. C. Chattipakorn, N. Chattipakorn |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84979021421&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/55169 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats
by: Tanajak P., et al.
Published: (2017) -
Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant rats
by: Pongpan Tanajak, et al.
Published: (2018) -
FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats
by: Piangkwan Sa-nguanmoo, et al.
Published: (2018) -
FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats
by: Piangkwan Sa-nguanmoo, et al.
Published: (2018) -
Letter to the editor: Parameters, characteristics, and criteria for defining the term "fGF21 resistance"
by: Pongpan Tanajak
Published: (2018)